Fresenius SE & Co. (OTCMKTS:FSNUY) Shares Gap Down – Should You Sell?

Fresenius SE & Co. (OTCMKTS:FSNUY) shares gapped down before the market opened on Thursday . The stock had previously closed at $15.13, but opened at $14.35. Fresenius SE & Co. shares last traded at $14.35, with a volume of 3,698 shares.

Wall Street Analyst Weigh In

A number of equities analysts recently commented on the company. Deutsche Bank Aktiengesellschaft reiterated a “buy” rating on shares of Fresenius SE & Co. in a research note on Monday, October 27th. Morgan Stanley reaffirmed an “overweight” rating on shares of Fresenius SE & Co. in a research note on Monday, December 15th. Two research analysts have rated the stock with a Buy rating, According to data from MarketBeat.com, the company presently has a consensus rating of “Buy”.

Fresenius SE & Co. Trading Down 4.7%

The firm has a market capitalization of $32.21 billion, a P/E ratio of 26.22 and a beta of 0.76. The business has a 50-day moving average price of $14.17 and a 200-day moving average price of $13.89. The company has a quick ratio of 0.99, a current ratio of 1.26 and a debt-to-equity ratio of 0.49.

Fresenius SE & Co. (OTCMKTS:FSNUY) last issued its earnings results on Wednesday, November 5th. The company reported $0.23 EPS for the quarter, topping the consensus estimate of $0.21 by $0.02. The company had revenue of $6.29 billion during the quarter, compared to the consensus estimate of $6.38 billion. Fresenius SE & Co. had a return on equity of 9.72% and a net margin of 5.26%. Analysts anticipate that Fresenius SE & Co. will post 0.79 earnings per share for the current year.

Fresenius SE & Co. Company Profile

Fresenius SE & Co KGaA is a global healthcare group headquartered in Bad Homburg vor der Höhe, Germany. Founded in 1912 by Eduard Fresenius, the company has grown into one of the world’s leading providers of products and services for dialysis, hospitals and outpatient medical care. Trading on major European exchanges and available over the counter in the U.S. as FSNUY, Fresenius SE & Co brings together a portfolio of specialized healthcare businesses under one corporate umbrella.

The company operates through four main business segments.